Voltron’s technology platform utilizes and more fully engages multiple components of the immune system to identify, target, and kill specific diseases for more effective treatments to improve patient outcomes.

This core capability of the platform drives an immune response that can attack a cancer target in multiple ways, and also has the capability to deliver a wide variety of therapies and multiple mechanisms of action.